Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 19,526 | 18,160 | 21,578 | 19,362 | 24,935 |
| Cost of Goods | 13,780 | 14,968 | 12,716 | 12,066 | 15,441 |
| Gross Profit | 5,746 | 3,192 | 8,862 | 7,296 | 9,494 |
| Operating Expenses | 37,149 | 28,830 | 31,323 | 31,311 | 30,464 |
| Operating Income | -30,623 | -24,670 | -21,745 | -23,949 | -20,529 |
| Interest Expense | 628 | 616 | 598 | 581 | 624 |
| Other Income | 452 | 242 | -197 | 351 | 391 |
| Pre-tax Income | -30,799 | -25,044 | -22,540 | -24,179 | -20,762 |
| Net Income Continuous | -30,799 | -25,044 | -22,540 | -24,179 | -20,762 |
| Net Income | $-30,799 | $-25,044 | $-22,540 | $-24,179 | $-20,762 |
| EPS Basic Total Ops | -0.20 | -0.19 | -0.17 | -0.20 | -0.16 |
| EPS Basic Continuous Ops | -0.21 | -0.19 | -0.17 | -0.20 | -0.16 |
| EPS Diluted Total Ops | -0.20 | -0.19 | -0.17 | -0.20 | -0.16 |
| EPS Diluted Continuous Ops | -0.21 | -0.19 | -0.17 | -0.20 | -0.16 |
| EBITDA(a) | $-28,929 | $-22,786 | $-19,843 | $-21,948 | $-18,479 |